MKS Instruments vs Philip Morris International Inc. — how do they compare? MKS Instruments trades at $268.04 (market cap $17.95B), while Philip Morris International Inc. trades at $185.71 (market cap $287.92B). The key difference: Philip Morris International Inc. is far larger — about 16× MKS Instruments's market cap, and Philip Morris International Inc. pays the higher dividend (3.18%). Which is the better fit depends on your goals.
| MKSI | PM | |
|---|---|---|
Market Cap | $17.95B | $287.92B |
Sector | Technology | Consumer Staples |
52-Week High | $444.80 | $200.17 |
52-Week Low | $110.60 | $144.33 |
Enterprise Value | $21.53B | $331.04B |
Dividend Yield | 0.38% | 3.18% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $185.71, up 1.74% with a bearish technical signal. Recent earnings show beats in Q1 and Q2 2026, but the company cut its 2026 profit forecast due to a $500 million impairment and cost pressures. Fundamentals remain strong with a 25.56% net margin and $11.35B net income in 2025, though high debt and illicit market growth in Europe pose risks. Analyst consensus is bullish with a $211.17 price target.
The stock offers a solid dividend and brand strength via IQOS, but faces headwinds from currency swings, energy costs, and regulatory challenges. Upside depends on execution amid margin pressure, with the current price near the low end of analyst targets suggesting cautious optimism for long-term investors.
Trailing returns across standard periods
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →